When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn’t just developing a COVID-19 vaccine — they also had to make it, and by the hundreds of millions.
Source: ctv business
Manufacturing moonshot: How Pfizer makes its millions of COVID-19 vaccine doses

